These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 11473907)

  • 1. Financial cost of social exclusion: follow up study of antisocial children into adulthood.
    Scott S; Knapp M; Henderson J; Maughan B
    BMJ; 2001 Jul; 323(7306):191. PubMed ID: 11473907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children.
    Dretzke J; Frew E; Davenport C; Barlow J; Stewart-Brown S; Sandercock J; Bayliss S; Raftery J; Hyde C; Taylor R
    Health Technol Assess; 2005 Dec; 9(50):iii, ix-x, 1-233. PubMed ID: 16336845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy.
    Beck EJ; Tolley K
    Int J STD AIDS; 1998 Sep; 9(9):512-7. PubMed ID: 9764934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis.
    Edwards RT; Céilleachair A; Bywater T; Hughes DA; Hutchings J
    BMJ; 2007 Mar; 334(7595):682. PubMed ID: 17350965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the cost of getting the price wrong?
    Beck EJ; Beecham J; Mandalia S; Griffith R; Walters MD; Boulton M; Miller DL
    J Public Health Med; 1999 Sep; 21(3):311-7. PubMed ID: 10528959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial.
    Petrou S; Bischof M; Bennett C; Elbourne D; Field D; McNally H
    Pediatrics; 2006 May; 117(5):1640-9. PubMed ID: 16651318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect cost of HIV infection in England.
    Mullins CD; Whitelaw G; Cooke JL; Beck EJ
    Clin Ther; 2000 Nov; 22(11):1333-45. PubMed ID: 11117658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study.
    Knapp M; Windmeijer F; Brown J; Kontodimas S; Tzivelekis S; Haro JM; Ratcliffe M; Hong J; Novick D;
    Pharmacoeconomics; 2008; 26(4):341-58. PubMed ID: 18370568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of treatments for children with severe behavioural problems.
    Muntz R; Hutchings J; Edwards RT; Hounsome B; O'Céilleachair A
    J Ment Health Policy Econ; 2004 Dec; 7(4):177-89. PubMed ID: 15701933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
    McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
    Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopy for Helicobacter pylori sero-negative young dyspeptic patients: an economic evaluation based on a randomized trial.
    Asante M; Lord J; Mendall M; Northfield T
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):851-6. PubMed ID: 10514116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.
    Int J STD AIDS; 1999 Jun; 10(6):357-62. PubMed ID: 10414877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
    Maslove L; Gower N; Spiro S; Rudd R; Stephens R; West P
    Thorax; 2005 Jul; 60(7):564-9. PubMed ID: 15994264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic consequences of early inpatient discharge to community-based rehabilitation for stroke in an inner-London teaching hospital.
    Beech R; Rudd AG; Tilling K; Wolfe CD
    Stroke; 1999 Apr; 30(4):729-35. PubMed ID: 10187870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of gastrostomy placement for children with neurodevelopmental disability.
    Townsend JL; Craig G; Lawson M; Reilly S; Spitz L
    Arch Dis Child; 2008 Oct; 93(10):873-7. PubMed ID: 18456697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic outcomes in adulthood and their associations with antisocial conduct, attention deficit and anxiety problems in childhood.
    Knapp M; King D; Healey A; Thomas C
    J Ment Health Policy Econ; 2011 Sep; 14(3):137-47. PubMed ID: 22116171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between TISS and ICU cost.
    Dickie H; Vedio A; Dundas R; Treacher DF; Leach RM
    Intensive Care Med; 1998 Oct; 24(10):1009-17. PubMed ID: 9840233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of services and associated costs for young adults with childhood hyperactivity/conduct problems: 20-year follow-up.
    D'Amico F; Knapp M; Beecham J; Sandberg S; Taylor E; Sayal K
    Br J Psychiatry; 2014 Jun; 204(6):441-7. PubMed ID: 24676966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial.
    Jones J; Wilson A; Parker H; Wynn A; Jagger C; Spiers N; Parker G
    BMJ; 1999 Dec; 319(7224):1547-50. PubMed ID: 10591720
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.